[HTML] cell.com

[HTML][HTML] Adjunct immunotherapies for the management of severely ill COVID-19 patients

SR Bonam, SV Kaveri, A Sakuntabhai, L Gilardin… - Cell Reports …, 2020 - cell.com
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). It has infected millions, with more than 275,000 fatal cases as …
被引用次数：129 相关文章
[PDF] u-bordeaux.fr

[PDF][PDF] Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients

SR Bonam, SV Kaveri, A Sakuntabhai, L Gilardin… - umfcs.u-bordeaux.fr
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). It has infected millions, with more than 275,000 fatal cases as …

Adjunct immunotherapies for the management of severely ill COVID-19 patients

SR Bonam, SV Kaveri, A Sakuntabhai… - Cell Reports …, 2020 - inserm.hal.science
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). It has infected millions, with more than 275,000 fatal cases as …

Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients

SR Bonam, SV Kaveri, A Sakuntabhai… - Cell reports …, 2020 - pubmed.ncbi.nlm.nih.gov
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). It has infected millions, with more than 275,000 fatal cases as …
[HTML] cell.com

[HTML][HTML] Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients

SR Bonam, SV Kaveri, A Sakuntabhai, L Gilardin… - Cell Reports …, 2020 - cell.com
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). It has infected millions, with more than 275,000 fatal cases as …

Adjunct immunotherapies for the management of severely ill COVID-19 patients

SR Bonam, SV Kaveri, A Sakuntabhai… - Cell Reports …, 2020 - pasteur.hal.science
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). It has infected millions, with more than 275,000 fatal cases as …
[PDF] regenhealthsolutions.info

[PDF][PDF] Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients

SR Bonam, SV Kaveri, A Sakuntabhai, L Gilardin… - regenhealthsolutions.info
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). It has infected millions, with more than 275,000 fatal cases as …

Adjunct immunotherapies for the management of severely ill COVID-19 patients

SR Bonam, SV Kaveri, A Sakuntabhai, L Gilardin… - Cell Reports …, 2020 - hal.science
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). It has infected millions, with more than 275,000 fatal cases as …

Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients.

SR Bonam, SV Kaveri, A Sakuntabhai… - Cell reports …, 2020 - europepmc.org
Abstract Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). It has infected millions, with more than 275,000 fatal …

Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients

SR Bonam, SV Kaveri, A Sakuntabhai… - Cell Reports …, 2020 - researchexperts.utmb.edu
Abstract Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). It has infected millions, with more than 275,000 fatal …